Concepedia

Ignacio Delgado Mingorance

ID

Statistics

Publications

4

Citations

642

H-Index

4

Active since

2019

Affiliations

Centro Oncológico de Galicia(Current)

Hospital Universitario Infanta Cristina

Ulsan College

Hospital Universitario Virgen Macarena

Institut Català d'Oncologia

Ignacio Delgado Mingorance is an author at Centro Oncológico de Galicia specializing in oncology, medicine, and gastrointestinal oncology.

Publications per year

2019–2023

4

Publications

4

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

, , +14

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

Peter Vink, Ignacio Delgado Mingorance, C. Maximiano Alonso et al. · Cancer · 2019 · 120 citations · Full text

, , +17

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis

Manuel Cobo, C. Beato Zambrano, Luis Cabezón Gutiérrez et al. · BMJ Supportive & Palliative Care · 2020 · 22 citations · Full text

, , +17

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

Manuel Cobo, C. Beato Zambrano, Luis Cabezón‐Gutiérrez et al. · BMJ Supportive & Palliative Care · 2021 · 12 citations · Full text

, , +17

1–4 of 4